Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 78 | BSPED2021 | Next issue

48th Meeting of the British Society for Paediatric Endocrinology and Diabetes

Online, Virtual
24 Nov 2021 - 26 Nov 2021

Card image cap

Oral Communications

Oral Communications 4

ea0078oc4.1 | Oral Communications 4 | BSPED2021

Dominant mutations in CCDC141 are found by ehole rxome dequencing to be a common cause of self-limited delayed puberty

Howard Sasha , Saengkaew Tansit , Dunkel Leo , Guasti Leonardo

Puberty is a fascinating transition period in the mammalian lifespan, but the biological control of pubertal timing remains poorly understood. Developmental abnormalities of the gonadotropin-releasing hormone (GnRH) neuronal network have been shown to be responsible for disorders of pubertal timing, in a spectrum of conditions ranging from idiopathic hypogonadotropic hypogonadism (IHH) to self-limited delayed puberty. We hypothesized that important regulators of pubertal timin...

ea0078oc4.2 | Oral Communications 4 | BSPED2021

Pseudohypoparathyroidism type 1A and 1B: presentation, phenotypes and phenotype-genotype associations

Prentice Philippa , Wilson Louise , Gevers Evelien , Buck Jackie , Raine Joseph , Rangasami Jayanti , McGloin Helen , Peters Catherine , Amin Rakesh , Wei Gan Hoong , Hughes Claire , Brain Caroline , Dattani Mehul , Allgrove Jeremy

Background & Objective: Pseudohypoparathyroidism (PHP), a heterogeneous condition, classically causes parathyroid hormone (PTH) resistance. PHP1a is caused by heterozygous inactivating mutations on the maternally derived GNAS allele. PHP1b results from methylation defects at the GNAS imprinted gene cluster, which are either sporadic, or familial, normally associated with maternally inherited intragenic STX16 deletions. We investigated the presentation, phenotype, ...

ea0078oc4.3 | Oral Communications 4 | BSPED2021

Growth hormone receptor 6Ω pseudoexon activation: a novel cause of severe growth hormone insensitivity

Cottrell Emily , Maharaj Avinaash , Williams Jack , Chatterjee Sumana , Cirillo Grazia , del Giudice Emanuele Miraglia , Festa Adalgisa , Palumbo Stefania , Capalbo Donatella , Salerno Mariacarolina , Pignata Claudio , Savage Martin O. , Schilbach Katharina , Bidlingmaier Martin , Hwa Vivian , Metherell Louise A. , Grandone Anna , Helen L. Storr

Context: Severe or ‘classical’ growth hormone insensitivity (GHI) is characterised by extreme short stature, dysmorphism and metabolic anomalies. It is caused by homozygous or compound heterozygous mutations of the Growth Hormone Receptor gene (GHR). Genetic analysis traditionally focuses on the exonic regions of gene(s). The non-coding regions of the genome may harbour numerous disease-causing mutations that are not well recognised or understood.<p clas...

ea0078oc4.4 | Oral Communications 4 | BSPED2021

Does Inflammation Underpin Polycystic Ovary Syndrome (PCOS)? A Proteomic Approach to Novel Non-Invasive Biomarker and Pathway Discovery in Adolescent PCOS

Gunn Harriet , Hallqvist Jenny , Doykov Ivan , Heywood Wendy , Steinbeck Katharine , Mills Kevin

Background and Methods: PCOS is common and associated with significant comorbidity. Yet, its pathogenesis is complex and poorly understood. We have developed new methods for deep phenotyping discovery proteomic profiling of urine to identify disease mechanisms and novel non-invasive biomarkers for PCOS in adolescents. We undertook proteomic analysis (nano 2D-LC-QTOF MSe) on a subset of 15 samples from a longitudinal PCOS cohort of 40 participants. We compared the ur...

ea0078oc4.5 | Oral Communications 4 | BSPED2021

The biochemical evaluation of Metabolic Bone Disease of Prematurity (MBDP) in a high-risk population

Watts Gemma , Young Aneurin , Johnson Mark John , Chowdhury Olie

Background: MBDP describes inadequate mineralisation of bones in the preterm infant. Traditionally, neonatologists have used a raised ALP and low phosphate to diagnose MBDP, with phosphate supplements as first-line treatment. An alternative management approach, published by Chinoy et al (2019), recommended PTH and vitamin D in the routine work-up. Objectives: We undertook a review of data across two neonatal intensive care units:<p class="ab...

ea0078oc4.6 | Oral Communications 4 | BSPED2021

The management of adrenal cell carcinoma in the United Kingdom at a single centre: a 25 year experience

Goff Nicole , Hughes Claire , Katugampola Harshini , Musthaq Imran , Hindmarsh Peter , Peters Catherine , Brain Caroline , Jorgensen Mette , Dattani Mehul

Background: Adrenal cortical carcinoma (ACC) in children is a rare and aggressive disease. Further characterisation of the presenting features and biochemical markers are needed to support earlier diagnosis. Refractory hypertension related to high cortisol concentrations at presentation, and post-operative decrease in cortisol can be challenging to manage. Focus on endocrine management has not been previously described.Case Series: 34 patients (age 2 wee...

ea0078oc4.7 | Oral Communications 4 | BSPED2021

The use of urinary steroid profiles in monitoring therapy in children with 21-hydroxylase deficiency – results from the CAH-UK cohort study

Bacila Irina , Lawrence Neil , Alvi Sabah , Cheetham Timothy , Crowne Elizabeth , Das Urmi , Dattani Mehul , Davies Justin H , Gevers Evelien , Krone Ruth , Kyriakou Andreas , Patel Leena , Randell Tabitha , Ryan Fiona , S Faisal Ahmed , Keevil Brian , Taylor Norman , Krone Nils

Introduction: Monitoring glucocorticoid (GC) replacement in patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) remains challenging. There are disease-specific patterns in the plasma and urinary steroid profiles in 21OHD, a key role being played by the 11-oxygenatedC19 androgens. Aim: To explore the urinary steroid profile in 21OHD in relation to treatment and plasma steroids. Methods: Partic...

ea0078oc4.8 | Oral Communications 4 | BSPED2021

Destination outcome of 1151 gender variant young people presenting to paediatric endocrinology clinics in England and Wales since 2008.

Butler Gary , Adu-Gyamfi Kirpal , Clarkson Kerry , Kleczewski Sara , Roberts Alice , Ward Stephanie , Alvi Sabah , Amin Nadia , Carruthers Paul , Dover Stacey , Eastman Joanna , Mushtaq Talat

Introduction: The destination of young people referred from the NHS Gender Identity Development Service (GIDS) to the two paediatric endocrine centres covering England and Wales has not been analysed previously.Methods: 1151 young people identifying as gender variant were referred from GIDS for an endocrine opinion: 827 patients to University College London Hospital (UCLH) from 2008; 324 to Leeds Children’s Hospital (LCH) from 2013. Outcomes were no...

ea0078oc4.9 | Oral Communications 4 | BSPED2021

The use of Liraglutide in the treatment of childhood obesity

Apperley Louise , Erlandson-Parry Karen , Gait Lucy , Laing Peter , Senniappan Senthil

Introduction: Childhood obesity remains a major health concern and there are a number of serious complications associated with it. These include type 2 diabetes mellitus (T2DM), obstructive sleep apnoea (OSA), idiopathic intracranial hypertension (IIH) and non-alcoholic fatty liver disease (NAFLD). Glucagon-like peptide 1 (GLP-1) therapy has shown promising results for weight loss in adults and has recently been approved for the use in the treatment of childhood obesity for ad...